Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

117 results about "Osmolyte" patented technology

Osmolytes are low-molecular weight organic compounds that influence the properties of biological fluids. Their primary role is to maintain the integrity of cells by affecting the viscosity, melting point, and ionic strength of the aqueous solution. When a cell swells due to external osmotic pressure, membrane channels open and allow efflux of osmolytes which carry water with them, restoring normal cell volume. Osmolytes also interact with the constituents of the cell, e.g. they influence protein folding. Common osmolytes include amino acids, sugars and polyols, methylamines, methylsulfonium compounds, and urea.

Environment-friendly non-silicon defoaming agent as well as preparation method and application thereof

The invention relates to the technical field of fine chemical engineering preparations, in particular to an environment-friendly non-silicon defoaming agent as well as a preparation method and application thereof. 3.6 to 5.1 parts of a defoaming aid; 0.24 to 0.35 part of a thickening agent; 2-3 parts of a dispersing agent; 2.6 to 3.5 parts of an emulsifier; 18 to 25.3 parts of an organic solvent; 65 to 82 parts of deionized water; wherein the polyether ester A and the polyether ester B with amphiphilic structures in the polyether ester can be quickly spread on the surface of foam, carry hydrophobic components to permeate a liquid membrane and accelerate foam breakage, and the defoaming assistant A and the defoaming assistant B further promote the defoaming and foam inhibition performance of the defoaming agent by reducing competitive adsorption to the defoaming agent and delaying release of active molecules. Compared with the prior art, the method has a wide application prospect.
Owner:JIANGSU SAIOUXINYUE DEFOAMER +1

Method for Stabilizing Hemoglobin and Reagents for Performing the Same

A stool resuspension solution comprising a hemoglobin stabilization reagent is provided. In some embodiments, the hemoglobin stabilization reagent may be an osmolyte, a polyvalent cation, a sugar or polysaccharide and, optionally, a polyvalent cation, a protoporphyrin, or an HRP stabilization component and, optionally, a polyvalent cation. A method of stabilizing hemoglobin in a stool sample in the solution is also provided, as well as a sample collection device containing the solution.
Owner:EXACT SCIENCES CORP

Preparation method of low-GI lactose-free milk

The invention provides a preparation method of low-GI lactose-free milk. The RO penetrating fluid obtained by the reverse osmosis technology is backfilled into the UF penetrating fluid, so that more salt ions in the UF penetrating fluid are eluted into a final product. The innovative process not only improves the natural nutritional value of the product, but also restores the original taste of the milk as much as possible. In addition, an INF (steam immersion sterilization) process is adopted, so that the taste of the cow milk is reserved to the maximum extent. Therefore, the milk powder is particularly suitable for patients with lactose intolerance, so that the patients can obtain richer nutrition and better taste experience while enjoying the delicious milk. In addition, the product is detected to belong to low-GI food, and people do not need to worry about increase of blood sugar when eating the product.
Owner:JUNLEBAO DAIRY GRP CO LTD

Device and method for the production of permeate, in particular for dialysis therapy

A water treatment plant or system for the production of permeate includes a reverse osmosis stage and a permeate stage. The reverse osmosis stage can include a piping system having a supply line for process input water, a reverse osmosis pump, and a reverse osmosis tank. The reverse osmosis tank has an inlet for process input water coming from the reverse osmosis pump, a membrane, and an outlet for permeate. The permeate stage, which can have a line system forming a circuit, can include a permeate tank, a permeate pump, and a tapping point for connecting at least one consumer or user of permeate. The reverse osmosis stage and the permeate stage can be connected to one another via a connecting line in such a way that the reverse osmosis stage feeds the permeate stage with permeate. The circuit of the permeate stage can include a sterile filter.
Owner:B BRAUN AVITUM

Recycling process and recycling system for acetic acid in process water of PTA (pure terephthalic acid) device

The invention relates to the field of terephthalic acid production devices, in particular to a system for recovering acetic acid in process water of a PTA (pure terephthalic acid) device, which comprises the following steps: step 1, cooling: cooling the process water of the PTA device to 18-20 DEG C; 2, impurity removal: removing impurities in the process water of the PTA device; step 3, performing primary reverse osmosis, namely performing primary reverse osmosis on the process water of the PTA device to generate primary penetrating fluid and primary retentate, and returning the primary retentate to the PTA mother liquor system for recycling; step 4, performing secondary reverse osmosis, namely performing secondary reverse osmosis on the primary penetrating fluid to generate secondary penetrating fluid and secondary retentate, outputting the secondary penetrating fluid, and returning the secondary retentate to the step 3 to perform the primary reverse osmosis; 5, cold energy recovery: recovering the cold energy of the final produced water for cooling in the step 1; the method has the following beneficial effects that the reverse osmosis membrane group is adopted, the acetic acid in the process water is recovered, and ten thousand tons of acetic acid are recovered every year according to 80t / h.
Owner:JIANGSU HONGGANG PETROCHEMICAL CO LTD

A facilitated permeation spiral-wound membrane module and membrane separation method

The application provides an assisted permeation roll type membrane assembly. Compared with the prior art, the assisted permeation roll type membrane assembly provided by the application can realize high concentration of raw liquid under low operating pressure; in addition, the membrane assembly can also be used in a forward osmosis membrane separation process. By introducing an assisted permeation liquid on the permeation liquid side of the RO or NF membrane in the assembly, the osmotic pressure on both sides of the membrane can be reduced, and then the pressure applied on the raw liquid side can be reduced, and the pressure can be regulated by adjusting the components of the assisted permeation liquid, so as to reduce the pressure and cost of solution concentration and improve the concentration ratio. The assisted permeation roll type membrane assembly provided by the application can be applied to industrial wastewater zero discharge, seawater desalination, material separation and other industrial fields, and can also be used as a forward osmosis, diffusion dialysis, gas separation, organic solvent nanofiltration and organic solvent reverse osmosis and other membrane separation processes in addition to reverse osmosis and nanofiltration.
Owner:CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES

Phosphorus recovery method and phosphorus recovery system for phosphogypsum leachate

The application discloses a phosphorus recovery method and system in phosphogypsum leachate, and relates to the technical field of environmental protection. The phosphorus recovery method comprises the following steps: adding calcium oxide into the phosphogypsum leachate, adjusting the pH value to 4, removing filter residues, removing COD through sand filtration and ultrafiltration; adjusting the pH value of the ultrafiltrate to 4, producing water through first nanofiltration, adjusting the pH value of the permeate to 10, collecting reaction generated gas into a second sedimentation tank for dissolution, continuously producing water through second nanofiltration, and obtaining concentrated water as phosphorus recovery liquid; collecting the first nanofiltration concentrated water and the second nanofiltration permeate, adding phosphate into the second sedimentation tank to obtain magnesium ammonium phosphate precipitation, and performing reverse osmosis treatment on the filtrate. The phosphorus recovery method provided by the application is simple in operation, low in cost, and can make the phosphorus recovery rate reach more than 90%, has a high removal rate of impurities such as F and S, and the obtained products in the treatment process can be recycled, and have high economic value.
Owner:SHANGHAI MINGNUO ENVIRONMENT TECH CO LTD

Injectable formulations for non-naturally occurring melanocortin analogs

PCT designated stageWO2026080411A1Organic active ingredientsMetabolism disorderOsmolyteMelanocortin 5 receptor
The present technology comprises stable aqueous pharmaceutical compositions and formulation comprising non-naturally occurring melanocortin analogs. In some embodiments, the non-naturally occurring melanocortin analogs may be agonists or antagonists of the melanocortin 5 receptor (MC5R) with sub-micromolar or low-nanomolar binding activity. In some embodiments, the present technology comprises a pharmaceutical composition having a pH of about 4.0 to about 6.5, comprising a non-naturally occurring melanocortin analog having at least one cationic amino acid residue, an osmolyte, a pH adjusting agent, and a buffer.
Owner:ENDEVICA BIO INC

Pure water production apparatus

PCT designated stageWO2026140499A1OsmolyteWater production
This pure water production apparatus comprises a reverse osmosis membrane and an electrodeionization device 2. In the electrodeionization device 2, anion exchange membranes 11 and cation exchange membranes 12 are alternately arranged between an anode plate 15 and a cathode plate 16, and by constituting compartments with the anion exchange membranes 11 and the cation exchange membranes 12, a desalting chamber 13 and a concentration chamber 14 are formed, and an anode chamber and a cathode chamber are formed at respective ends. As feed water to the desalting chamber 13, permeated water W1 from a reverse osmosis membrane device 1 is supplied to the desalting chamber 13 to obtain treated water W2. Further, as feed water W3 to the concentration chamber 14, permeate from the reverse osmosis membrane device 1 is supplied, and concentrated water W4 is discharged. In the electrodeionization device 2, the desalting chamber 13 is filled with substantially 100% by weight of an anion exchange resin. According to this pure water production apparatus, the removal efficiency of weak acid ions such as boron and silica can be improved without using chemicals.
Owner:KURITA WATER INDUSTRIES LTD

Waste liquid treatment method, boric acid recovery production method, and method for producing polarizing plate

This waste liquid treatment method for selectively recovering boric acid from a waste liquid generated in a polarizing plate manufacturing process comprises a first membrane separation step for passing the waste liquid having a pH of 8.5 or less or the waste liquid pH-adjusted to a pH of 8.5 or less through a first separation membrane module provided with a reverse osmosis membrane to separate the waste liquid into a first permeate including boric acid (B1) and a substance (R1) other than boric acid in the waste liquid and a first concentrated liquid including the boric acid (B2) and a substance (R2) other than boric acid in the waste liquid, and a boric acid concentration crystallization step for recovering boric acid by concentration crystallization of the first permeate obtained by the first membrane separation step.
Owner:NITTO DENKO CORP

Water treatment equipment and method of operating the water treatment equipment

PendingJP2026122713AOsmolyteReverse osmosis
The present invention provides a water treatment device that can efficiently concentrate and discharge difficult-to-remove substances from the system without degrading the water quality of the permeate from the first reverse osmosis membrane. [Solution] The water treatment device 1 includes a water treatment tank 2 for storing water to be treated W, a high-pressure pump 3 for supplying the pre-treated water W, a first reverse osmosis membrane 4, a concentrated water tank 5 for storing the concentrated water W1 from the first reverse osmosis membrane 4, a high-pressure pump 6, and a second reverse osmosis membrane 7 for treating the concentrated water W1 from the first reverse osmosis membrane 4. The permeate water W2 from the second reverse osmosis membrane 7 is returned to the water treatment tank 2, and the concentrated water from the second reverse osmosis membrane 7 is discharged. The first reverse osmosis membrane 4 and the second reverse osmosis membrane 7 are reverse osmosis membranes having a permeate flow rate of 0.5 m / day or more and 1.0 m / day or less at an effective membrane surface pressure of 2 MPa (water temperature 25°C, pure water), or a permeate flow rate of 0.5 m / day or more and 1.0 m / day or less at an effective membrane surface pressure of 1.5 MPa (water temperature 25°C, pure water).
Owner:KURITA WATER INDUSTRIES LTD

RO (Reverse Osmosis) acetic acid recovery system

The utility model provides an RO (Reverse Osmosis) acetic acid recovery system. The RO acetic acid recovery system comprises an RO water inlet buffer tank, a primary reverse osmosis membrane group and a secondary reverse osmosis membrane group, the liquid inlet end of the RO water inlet buffer tank is connected with an RO water inlet pipe; the output end of the buffer tank is sequentially connected with a reverse osmosis low-pressure pump and a reverse osmosis high-pressure pump through a conveying pipeline; the output end of the reverse osmosis high-pressure pump is connected with the primary reverse osmosis membrane group through a pipeline; one end, provided with a double-pipeline output end, of the second-stage reverse osmosis membrane group is connected with a liquid inlet end of the first-stage RO water production tank, and the other end of the second-stage reverse osmosis membrane group is connected with a liquid return opening of the RO water inlet buffer tank; the penetrating fluid conveying pump is connected with the sewage treatment device through an output pipeline; and a conveying pipeline connected with a liquid return port of the secondary RO water production tank is arranged on the output pipeline between the penetrating fluid conveying pump and the sewage treatment device. According to the RO acetic acid recovery system disclosed by the utility model, the recovery rate of acetic acid in water is improved, the consumption of fresh acetic acid is reduced and considerable economic benefits are brought to enterprises by arranging two groups of reverse osmosis membrane group operation loads.
Owner:HENGLI PETROCHEMICAL (HUIZHOU) CO LTD

Water treatment system, reverse osmosis membrane apparatus operation method, control device, and program

This water treatment system provides optimal blockage suppression treatment that can be performed according to the fouling risk of two or more types of raw water. [Solution] The water treatment system 1 includes a reverse osmosis membrane device 6 that separates mixed water, obtained by mixing multiple raw waters of different water qualities, into permeate and concentrated water; a clogging suppression means 9 that suppresses clogging of the reverse osmosis membrane of the reverse osmosis membrane device; a flow rate measuring means 11 that measures the flow rate of each of the multiple raw waters; and a control device 10 that obtains the flow rate ratio of the multiple raw waters based on the measurement value of the flow rate measuring means 11 and controls the clogging suppression operation of the clogging suppression means 9 in stages according to the flow rate ratio.
Owner:ORGANO CORP

Novel method for efficiently removing sulfate radicals in sodium chloride system

The invention is applicable to the technical field of removal of sodium sulfate in saline water, and provides a novel method for efficiently removing sulfate radicals in a sodium chloride system, which specifically comprises the following steps: firstly, taking the saline water with the sodium chloride concentration of 200-220g / L and the sodium sulfate concentration of 30-80g / L, then adding pure water, diluting the saline water until the sodium chloride concentration is 100-110g / L and the sodium sulfate concentration is 15-40g / L, and then adding the pure water into the saline water until the sodium chloride concentration is 100-110g / L and the sodium sulfate concentration is 15-40g / L; then the diluted saline water is fed into a nanofiltration membrane set, penetrating fluid and concentrated liquid are separated out through the nanofiltration membrane set, the penetrating fluid is fed into the next procedure, the concentration of sodium chloride in the produced concentrated liquid is 100-110 g / L, and the concentration of sodium sulfate in the produced concentrated liquid is 100-200 g / L. On the basis of an existing technology for removing sulfate radicals from chlor-alkali through a saline water membrane separation method, secondary treatment of the concentrated solution through the membrane separation method is achieved through the advanced concept technology, the recycling rate of sodium chloride in light salt brine after electrolysis is increased, the concentration of the sulfate radicals in the concentrated solution is increased, the treatment cost of the concentrated solution is reduced, and the purposes of reducing cost and improving efficiency are achieved.
Owner:HENGXINGRUNFENG TECH DEV BEIJING

Systems and methods for recovering carbon dioxide from a foamed acid hydraulic fracturing operation

A method for recovering carbon dioxide from a foamed acid hydraulic fracturing operation, the method comprising: introducing a foamed acid from a surface location into a wellbore fluidly connected to a subsurface formation, the foamed acid comprising an aqueous solution, an acid, and carbon dioxide; exposing the foamed acid to a first zone of the subsurface formation, thereby inducing one or more fractures in the first zone of the subsurface formation; receiving a return portion of the foamed acid from the subsurface formation at the surface location via the wellbore; and introducing the return portion of the foamed acid to a separation unit comprising a polybenzimidazole (PBI) membrane, thereby forming a carbon dioxide-rich permeate stream and a carbon dioxide-poor retentate stream.
Owner:SAUDI ARABIAN OIL CO

Method for stabilizing hemoglobin and reagents for carrying it out

A stool resuspension comprising a hemoglobin stabilizing reagent is provided.SOLUTION: In some embodiments, the hemoglobin stabilizing reagent may be an osmolyte, a multivalent cation, a sugar or polysaccharide, and optionally a multivalent cation, a protoporphyrin, or an HRP stabilizing component, and optionally a multivalent cation. Also provided are methods of stabilizing hemoglobin in a stool sample in a solution, and sample collection devices comprising the solution.SELECTED DRAWING: None
Owner:EXACT SCIENCES CORP

Method for treating waste liquid, method for recovering and producing boric acid, and method for producing polarizing plate

A method for treating waste liquid according to the present invention comprises: a boric acid adsorption step for selectively adsorbing boric acid onto an adsorbent from a waste liquid having a pH adjusted to be alkaline; a boric acid desorption step for bringing an acidic solution into contact with the adsorbent to cause the boric acid to elute from the adsorbent into the acidic solution to obtain an eluate; an NF membrane separation step for adding a base to the eluate and passing the eluate that has been pH adjusted further to the acidic side from neutral through a NF membrane to separate the eluate into a permeate containing the boric acid without containing acid-derived anions or base-derived cations, and a concentrate containing acid-derived anions and base-derived cations; and a boric acid recovery step for recovering boric acid from the permeate.
Owner:NITTO DENKO CORP

Method of treatment via intra-articular application of potassium

Resolution of a pathological condition is promoted via the application, e.g., via injection, of a potassium osmolyte such as hyperosmolar potassium gluconate, potassium aspartate, another potassium-based salt, or combinations thereof to the condition site. The application of the potassium osmolyte increases the extracellular concentration of potassium ions, reducing the membrane potential of the cells at the condition site and including immune cell quiescence. As a result, the inflammatory response in the patient to the pathological condition is reduced or eliminated. Reducing the inflammatory response is useful in treatment of myriad conditions including arthritis, auto-immune conditions, inflammatory disorders, neurodegenerative disorders, neurodevelopmental disorders, tissue breakdown, etc.
Owner:RENESSELAER POLYTECHNIC INST

Method for producing gaseous dihydrogen and ammonium sulfate from an aqueous liquid effluent, such as the liquid fraction of a pig manure or human urine

The invention concerns a process for producing gaseous dihydrogen and ammonium sulphate from an aqueous liquid effluent containing organic and inorganic materials or a mixture of aqueous liquid effluents,said process comprising the following steps:nanofiltration of said aqueous liquid effluent or said mixture of aqueous liquid effluents so as to obtain a permeate;ammonia stripping of the permeate from said nanofiltration step in an ammonia stripping unit so as to obtain an ammonium sulphate;treatment by reverse osmosis of at least part of the permeate extracted from the ammonia stripping unit after said ammonia stripping step, so as to obtain an osmosed aqueous solution;electrolysis of at least part of said osmosis aqueous solution so as to decompose said part of said osmosis aqueous solution into at least gaseous dihydrogen.
Owner:SANOFAGRI

Process and system for producing hydrogenated drinking water

A process and system for producing a hydrogenated drinking water has a reverse osmosis filter, an ionizer and a power supply. The reverse osmosis filter has an inlet on one side thereof and first and second outlets on an opposite side thereof. The first outlet is adapted to pass a permeate from the reverse osmosis filter. The second outlet is adapted to pass brine from the reverse osmosis filter. The ionizer is in fluid communication with the reverse osmosis filter. The ionizer has a first inlet connected to the first outlet of the progress osmosis filter. The ionizer has a second inlet connected to the second outlet of the reverse osmosis filter. The power supply is connected to the ionizer so as to electrolysize the brine and the permeate.
Owner:CORE PACIFIC INC

Preparation process for extracting wrinkled gianthyssop herb essential oil

The invention discloses a preparation process for extracting wrinkled gianthyssop herb essential oil, and relates to the field of plant essential oil extraction. The preparation process comprises the steps of surface oxidation damage treatment, high penetrating fluid treatment pulping, osmotic pressure impact-ultrasonic wall breaking pretreatment, coalescence oil-water separation, adsorption decoloration and impurity removal, segmented steam condensation impurity removal and the like. The prepared essential oil is small in toxic and side effects and good in safety, plant cell walls are effectively destroyed by treating the raw materials through surface oxidation, osmotic pressure impact and ultrasonic wall breaking, and the release efficiency of the essential oil is improved. And the whole extraction process is simple to operate and high in extraction efficiency, and pure agastache rugosus essential oil can be rapidly obtained.
Owner:ZHANJIANG LETIAN AGRI TECH CO LTD

Methods for determining the amount of encapsulated and free iron in a sample

This invention provides methods for quantitatively determining the concentration of free iron and ferritin-bound iron in a sample. The method includes diluting a ferritin-containing sample with a diluent to create a slurry, processing the slurry through a crossflow filtration system equipped with a membrane of at least 500 kilodaltons molecular weight cutoff, collecting the permeate containing free iron and the retentate containing ferritin-bound iron analyzing the iron concentrations in the permeate and retentate using a suitable analytical technique and calculating the mass balance of the total iron content. The invention also provides an antibody for use in quantitating the amount of ferritin in a sample and methods of treating iron deficiency in a patient in need thereof.
Owner:SLOIRON INC

Device and method for the production of permeate, in particular for dialysis therapy

Main requirement: Water treatment plant for the production of permeate, especially for dialysis therapy, comprising • a reverse osmosis stage (137) with a piping system comprising a supply line (131) for process inlet water (100), a reverse osmosis pump (103) and a reverse osmosis tank (130), wherein the reverse osmosis tank (130) has an inlet (143) for the process inlet water (100) coming from the reverse osmosis pump (103), a membrane (104) and an outlet (144) for permeate (108), • a permeate stage (139) with a circulating piping system comprising a permeate tank (112), a permeate pump (114) and a take-off point (134) for connecting at least one consumer or user of permeate (108), wherein the reverse osmosis stage (137) and the permeate stage (139) are connected to each other via a connecting line (138) such that the reverse osmosis stage (137) feeds the permeate stage (139) with permeate (108), and wherein the circuit of the permeate stage (138) comprises a sterile filter (116).
Owner:B BRAUN AVITUM

Multistage reverse osmosis membrane treatment system

To provide a multistage reverse osmosis membrane treatment system capable of obtaining treated water of high quality while suppressing operation energy.SOLUTION: A multistage reverse osmotic membrane treatment system 1 is equipped with a storage tank 2 for storing W0 to be treated and the water supply pipe 3 connected to the storage tank 2 and a liquid supply pump 4, a first reverse osmotic membrane 5 and a second reverse osmotic membrane 6 are successively provided to the water supply pipe 3. An aqueous NaOH soln. adding means 7 is connected to the front stage of the second reverse osmotic membrane 6 and the addition amt. of an aqueous NaOH soln. can be controlled so that the water to be treated of the second reverse osmotic membrane 6 becomes an alkali region corresponding to the flow amt. of the water passing pipe 3 and the pH of the W0 of the water to be treated. The first reverse-osmosis membrane 5 has a permeation flow rate of 2. 1MPa / (0m3·day) or more per membrane surface effective pressure m2 (water temperature 25 °C., pure water (RO permeate)), and the second reverse-osmosis membrane 6 has a permeation flow rate of 0. 1MPa / (8m3·day) or more and less than 2. m2 / (0m3·day) per membrane surface effective pressure m2 (water temperature 25 °C., pure water (RO permeate)).SELECTED DRAWING: Figure 1
Owner:KURITA WATER INDUSTRIES LTD

Compositions and methods for RNA synthesis

Compositions and methods for synthesizing an RNA product are provided herein. For example, the present disclosure provides a method of producing an RNA product comprising incubating an in vitro transcription mixture, thereby producing an RNA product that comprises a plurality of single-stranded RNA molecules. In some embodiments, an in vitro transcription mixture comprises a DNA template comprising an RNA polymerase promoter sequence operatively linked to a target sequence; at least one RNA polymerase that recognizes the RNA polymerase promoter sequence; a plurality of ribonucleotides comprising at least two different types of ribonucleotides, each type comprising a different nucleoside; and a transcription buffer comprising an osmolyte.
Owner:HELIX NANOTECHNOLOGIES INC

Closed-circuit continuous seawater desalination system

The invention relates to a reverse osmosis water treatment device (2) comprising: - at least one reverse osmosis membrane unit configured to extract a permeate from water to be desalinated, - at least one supply line for water to be treated (8) to the membrane unit, - at least one outlet line (16) for a concentrate from the membrane unit, - at least one reservoir (24), - at least one discharge line (26) for the concentrate to the reservoir (24), - at least one refill line for the reservoir (24) with water to be treated, the desalination device (2) being characterized in that the reservoir (24) extends mainly along a first substantially vertical axis and further comprises a lower connection (52) connected to the discharge line (26) for the concentrate and an upper connection (54) fluidly connected to the delivery line (32) for the water to be treated. Figure for the summary: Figure 1
Owner:SUEZ INTERNATIONAL

Renewable energy source using pressure driven filtration processes and systems

Some embodiments relates generally to the production of a desalinated, filtrated or other way treated water simultaneously with generation of renewal energy source, in particular hydrogen, using osmotic and / or gauge pressure driven filtration processes and systems. The co-generation of hydrogen 11 from water 8 produced during pressure driven water desalination / filtration processes, such as reverse osmosis, forward osmosis, pressure retarded osmosis or ultrafiltration. A small part of feed, raw saline solution and / or permeate involved in a desalination / filtration processes is subjected to electrolysis thereby splitting the water to produce hydrogen. This is achieved by the provision of novel RO type semi-permeable membranes and UF type membrane that incorporate electrodes 9, 10 within the membrane to allow splitting of the water via electrolysis.
Owner:IDE WATER TECH LTD

Stabilized formulations of insulin and insulin analogs

PCT designated stageWO2026096588A1Metabolism disorderPeptide/protein ingredientsInsulin activityGlulisine insulin
A pharmaceutical formulation presented, comprising an insulin or an insulin analog, and at least one protective excipient, in high concentration, selected from: a protective osmolyte, a surfactant, and a phenolic preservative. In embodiments, the insulin or insulin analog is one or more of: regular human insulin, insulin lispro, insulin aspart, insulin glulisine, insulin glargine, insulin detemir, or insulin degludec. In some embodiments, at least one of: the concentration of the protective osmolyte confers an osmolarity greater than 250 mOsm / L, the concentration of the surfactant is greater than 0.1% w / v, or the concentration of the phenolic preservative is greater than 0.4% w / v. In some embodiments, insulin API is dissolved and incubated for 20 to 40 minutes at high pH before the protective excipients are added.
Owner:PORTAL DIABETES INC